Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
China working on concessions to help homegrown companies stay on US exchanges — report
4 years ago
China
Pfizer pitches 4th Covid-19 vaccine shot for elderly despite mixed data from Israel
4 years ago
Coronavirus
White House sounds the alarm on Covid-19 vaccine, monoclonal supply shortages
4 years ago
Coronavirus
Genome editing products: FDA recommends at least 15 years of follow-up after clinical trials
4 years ago
Cell/Gene Tx
FDA orders Incyte to hold up yet again in the hunt for blockbuster franchise
4 years ago
Moving up the treatment lines, AstraZeneca clinches adjuvant breast cancer OK for Lynparza
4 years ago
Pharma
FDA hits back Fasenra in key rhinosinusitis field, putting AstraZeneca even further behind Big Pharma rivals
4 years ago
Pharma
Senators call on CMS to finalize pharmacy fee reforms to save seniors $21B in out-of-pocket expenses
4 years ago
Pharma
SEC singles out Zai Lab, BeiGene, Hutchmed for regulatory scrutiny — with threats of delisting
4 years ago
China
FDA lifts a clinical hold on Selecta gene therapy after another delay hampers R&D plans
4 years ago
R&D
Updated: Three big Congressional hearings next week to set the tenor on accelerated approvals, pandemics, drug prices, and ARPA-H
4 years ago
Pharma
FDA's oncology adcomm to review PI3K inhibitors in blood cancers in April
4 years ago
R&D
Last-minute US spending bill features a beginning for ARPA-H, and half of what Biden requested for Covid-19
4 years ago
Coronavirus
FDA resurrects proposal to gauge quality metrics in pharma manufacturing
4 years ago
Manufacturing
Overhauling FDA's accelerated approval pathway: Key House committee chair pens new bill
4 years ago
Real world data and FDA: Drugmakers seek more clarity on registry guidance
4 years ago
R&D
A checkpoint 2.0 drug runs into trouble as Alpine gets hit with the latest in a string of clinical holds
4 years ago
FDA hands Bristol Myers a landmark approval in early-stage lung cancer after just five days
4 years ago
Aurinia faces choppy waters amid lower-than-expected 2022 guidance and patent challenge on Lupkynis
4 years ago
Pharma
Marketing
FDA pushes back a review date for TG's 'U2' combo as the biotech steels itself for upcoming adcomm
4 years ago
Two Republican senators call on CMS to not restrict coverage to amyloid-targeted Alzheimer's drugs
4 years ago
FDA begins court-mandated release of thousands of pages on Pfizer's Covid-19 vaccine review
4 years ago
Coronavirus
As GSK is forced to slam the brakes, Pfizer cruises ahead with a ‘breakthrough’ on RSV
4 years ago
FDA slaps hold on Finch's microbiome C. difficile treatment, as biotech blames Covid-19 and old manufacturer
4 years ago
R&D
First page
Previous page
86
87
88
89
90
91
92
Next page
Last page